Skip Navigation



NDT Advance Access published online on January 14, 2009

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn730
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/5/1568    most recent
gfn730v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kang, E. W.
Right arrow Articles by Han, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, E. W.
Right arrow Articles by Han, S. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Prognostic value of elevated cardiac troponin I in ESRD patients with sepsis

Ea Wha Kang1,2, Hyoung Jung Na1, Sug Min Hong1, Sug Kyun Shin1, Shin-Wook Kang2, Kyu Hun Choi2, Ho Yung Lee2, Dae-Suk Han2 and Seung Hyeok Han1,2

1 Department of Internal Medicine, NHIC IIsan Hospital, Goyangshi, Gyunggi-do 2 Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

Correspondence and offprint requests to: Seung Hyeok Han, Department of Internal Medicine, NHIC IIsan Hospital, 1232 Baeksok-dong, Goyangshi, Gyunggi-do 410-719, Korea. Tel: +82-31-900-0246; Fax: +82-31-900-0343; E-mail: anythingbox70{at}gmail.com



  Abstract

Background. Elevated cardiac troponin (cTn) levels have been reported to predict adverse cardiovascular outcomes in asymptomatic ESRD patients. However, the prognostic value of elevated cTn levels associated with sepsis in ESRD patients is unknown. Therefore, this study aimed to elucidate the clinical implications of elevated cTnI levels in ESRD patients with sepsis.

Methods. Of the 305 ESRD patients in whom cTnI was measured between January 2003 and December 2005, sepsis developed in 121 patients during follow-up. Based on cTnI levels at the onset of sepsis, patients were classified as elevated cTnI group (ET, n = 50, >0.2 ng/ml) and lower cTnI group (LT, n = 71, ≤0.2 ng/ml). Study endpoints were short- and long-term mortality. Short-term mortality was defined as death occurring within 90 days after sepsis, and patients who survived during this period were followed till death after 90 days.

Results. Before sepsis, the median concentration of cTnI was 0.05 (0.01–3.59) ng/ml and it was significantly increased to 0.11 (0.01–22.0) ng/ml when sepsis supervened (P < 0.01). Compared to the LT group, the short-term mortality rate was significantly higher in the ET group (P < 0.05). After adjustment for age, diabetes, serum albumin and CRP levels, presence of shock and previous cardiovascular disease history, the ET group had a greater odds ratio of short-term mortality (OR 5.13, P < 0.01). In addition, the Kaplan–Meier plot for long-term survival revealed a significantly higher mortality rate in the ET group. In a multivariate Cox regression analysis, the elevation of cTnI levels was an independent determinant for long-term mortality (HR 5.90, P < 0.01).

Conclusion. This study showed that elevated cTnI levels were significantly associated with short- and long-term mortality in ESRD patients with sepsis. Therefore, elevated cTnI levels in these patients should not be overlooked and be followed for adverse outcomes.

Keywords: cardiac troponin I; ESRD; sepsis

Received for publication: 13.10.08
Accepted in revised form: 5.12.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.